Abstract
Head and neck radiotherapy is accompanied by deleterious effects of radiation to healthy tissues. The clinical consequences of the effects of radiotherapy on the salivary glands include a reduced salivary secretion (hyposalivation) and accompanying sensation of oral dryness (xerostomia) due to damage to the salivary glands, taste loss, and the lifelong threat of developing caries, oral infections, and osteoradionecrosis. While taste loss is a reversible consequence that usually subsides early in postirradiation, hyposalivation is normally irreversible. This chapter focuses on the long-term effects of radiotherapy on the salivary glands and dentition. The clinical picture of xerostomia and hyposalivation-related dental caries is described, and guidelines are given on how to manage xerostomia and how to prevent hyposalivation-related sequelae such as dental caries.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Sreebny LM, Vissink A, editors. Dry mouth. The malevolent symptom: a clinical guide. Wiley-Blackwell: Ames, IA; 2010.
Dawes C, Pedersen AM, Villa A, Ekström J, Proctor GB, Vissink A, et al. The functions of human saliva: a review sponsored by the world workshop on oral medicine VI. Arch Oral Biol. 2015;60:863–74.
Javaid MA, Ahmed AS, Durand R, Tran SD. Saliva as a diagnostic tool for oral and systemic diseases. J Oral Biol Craniofac Res. 2016;6:66–75.
Ship JA, Fox PC, Baum BJ. Normal salivary gland function: how much saliva is enough? J Am Dent Assoc. 1991;122:63–9.
Dawes C, Odlum O. Salivary status in patients treated for head and neck cancer. J Can Dent Assoc. 2004;70:397–400.
Jensen SB, Vissink A, Limesand KH, Reyland ME. Salivary gland hypofunction and xerostomia in head and neck radiation patients. J Natl Cancer Inst. 2018; (in press).
Vissink A, Jansma J, Spijkervet FK, Burlage FR, Coppes RP. Oral sequelae of head and neck radiotherapy. Crit Rev Oral Biol Med. 2003;14:199–212.
Sciubba JJ, Goldenberg D. Oral complications of radiotherapy. Lancet Oncol. 2006;7:175–83.
Beetz I, Schilstra C, Visink A, van der Schaaf A, Bijl HP, van der Laan BF, et al. Role of minor salivary glands in developing patient-rated xerostomia and sticky saliva during day and night. Radiother Oncol. 2013;109:311–6.
Berthrong M. Pathologic changes secondary to radiation. World J Surg. 1986;10:155–70.
Konings AW, Coppes RP, Vissink A. On the mechanism of salivary gland radiosensitivity. Int J Radiat Oncol Biol Phys. 2005;62:1187–94.
Dardick I, Byard RW, Carnegie JA. A review of the proliferative capacity of major salivary glands and the relationship to current concepts of neoplasia in salivary glands. Oral Surg Oral Med Oral Pathol. 1990;69:53–67.
Burlage FR, Coppes RP, Meertens H, Stokman MA, Vissink A. Parotid and submandibular/sublingual salivary flow during high dose radiotherapy. Radiother Oncol. 2001;61:271–4.
Coppes RP, Vissink A, Konings AW. Comparison of radiosensitivity of rat parotid and submandibular glands after different radiation schedules. Radiother Oncol. 2002;63:321–8.
Nagler RM. The enigmatic mechanism of irradiation-induced damage to the major salivary glands. Oral Dis. 2002;8:141–6.
Vissink A, van LP, Langendijk JA, Coppes RP. Current ideas to reduce or salvage radiation damage to salivary glands. Oral Dis. 2015;21:e1–10.
Murdoch-Kinch CA, Kim HM, Vineberg KA, Ship JA, Eisbruch A. Dose-effect relationships for the submandibular salivary glands and implications for their sparing by intensity modulated radiotherapy. Int J Radiat Oncol Biol Phys. 2008;72:373–82.
Dijkema T, Raaijmakers CPJ, Ten Haken RK, Roesink JM, Braam PM, Houweling AC, et al. Parotid gland function after radiotherapy: the combined Michigan and Utrecht experience. Int J Radiat Oncol Biol Phys. 2010;78:449–53.
Jensen SB, Pedersen AML, Vissink A, Andersen E, Brown CG, Davies AN, et al. A systematic review of salivary gland hypofunction and xerostomia induced by cancer therapies: prevalence, severity and impact on quality of life. Support Care Cancer. 2010;18:1039–60.
Jen YM, Lin YC, Wang YB, Wu DM. Dramatic and prolonged decrease of whole salivary secretion in nasopharyngeal carcinoma patients treated with radiotherapy. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2006;101:322–7.
Lombaert IM, Brunsting JF, Wierenga PK, Kampinga HH, de HG, Coppes RP. Keratinocyte growth factor prevents radiation damage to salivary glands by expansion of the stem/progenitor pool. Stem Cells. 2008;26:2595–601.
Coppes RP, Stokman MA. Stem cells and the repair of radiation-induced salivary gland damage. Oral Dis. 2011;17:143–53.
van Luijk P, Pringle S, Deasy JO, Moiseenko VV, Faber H, Hovan A, Baanstra M, et al. Sparing the region of the salivary gland containing stem cells preserves saliva production after radiotherapy for head and neck cancer. Sci Transl Med. 2015;7:305ra147.
Fox PC, Busch KA, Baum BJ. Subjective reports of xerostomia and objective measures of salivary gland performance. J Am Dent Assoc. 1987;115:581–4.
Mizutani S, Ekuni D, Tomofuji T, Azuma T, Kataoka K, Yamane M, et al. Relationship between xerostomia and gingival condition in young adults. J Periodontal Res. 2015;50:74–9.
Schuurhuis JM, Stokman MA, Roodenburg JL, Reintsema H, Langendijk JA, Vissink A, et al. Efficacy of routine pre-radiation dental screening and dental follow-up in head and neck oncology patients on intermediate and late radiation effects. A retrospective evaluation. Radiother Oncol. 2011;101:403–9.
Schuurhuis JM, Stokman MA, Witjes MJ, Langendijk JA, van Winkelhoff AJ, Vissink A, et al. Head and neck intensity modulated radiation therapy leads to an increase of opportunistic oral pathogens. Oral Oncol. 2016;58:32–40.
Jongebloed WL, ‘s-Gravenmade EJ, Retief DH. Radiation caries. A review and SEM study. Am J Dent. 1988;1:139–46.
Jansma J, Vissink A, Jongebloed WL. Natural and induced radiation caries. A SEM study. Am J Dent. 1993;6:130–6.
Kielbassa AM, Hinkelbein W, Hellwig E, Meyer-Lückel H. Radiation-related damage to dentition. Lancet Oncol. 2006;7:326–35.
Lieshout HF, Bots CP. The effect of radiotherapy on dental hard tissue--a systematic review. Clin Oral Investig. 2014;18:17–24.
AAOM Clinical Practice Statement: subject: clinical management of cancer therapy-induced salivary gland hypofunction and xerostomia. Oral Surg Oral Med Oral Pathol Oral Radiol. 2016;122(3):310–2.
Mouly S, Salom M, Tillet Y, et al. Management of xerostomia in older patients: a randomised controlled trial evaluating the efficacy of a new oral lubricant solution. Drugs Aging. 2007;24:957–65.
Mouly SJ, Orler JB, Tillet Y, et al. Efficacy of a new oral lubricant solution in the management of psychotropic drug-induced xerostomia: a randomized controlled trial. J Clin Psychopharmacol. 2007;27:437–43.
Vissink A, De Jong HP, Busscher HJ. Wetting properties of human saliva and saliva substitutes. J Dent Res. 1986;65:1121–4.
Johnson JT, Ferretti GA, Nethery WJ, et al. Oral pilocarpine for post-irradiation xerostomia in patients with head and neck cancer. N Engl J Med. 1993;329:390–5.
Vivino FB, Al-Hashimi I, Khan Z, et al. Pilocarpine tablets for the treatment of dry mouth and dry eye symptoms in patients with Sjögren’s syndrome: a randomized, placebo-controlled, fixed-dose, multicenter trial. P92-01 study group. Arch Int Med. 1999;159:174–81.
Petrone D, Condemi JJ, Fife R, et al. A double-blind, randomized, placebo-controlled study of cevimeline in Sjögren’s syndrome patients with xerostomia and keratoconjunctivitis sicca. Arthritis Rheum. 2002;46:748–54.
Fife RS, Chase WF, Dore RK, et al. Cevimeline for the treatment of xerostomia in patients with Sjögren’s syndrome: a randomized trial. Arch Intern Med. 2002;162:1293–300.
Jensen SB, Pedersen AML, Vissink A, et al. A systematic review of salivary gland hypofunction and xerostomia induced by cancer therapies: management strategies and economic impact. Support Care Cancer. 2010;18:1061–79.
Chambers MS, Jones CU, Biel MA, et al. Open-label, long-term safety study of cevimeline in the treatment of postirradiation xerostomia. Int J Radiat Oncol Biol Phys. 2007;69:1369–76.
Wiseman LR, Faulds D. Oral pilocarpine: a review of its pharmacological properties and clinical potential in xerostomia. Drugs. 1995;49:143–55.
Jedel E. Acupuncture in xerostomia – a systematic review. J Oral Rehabil. 2005;32:392–6.
Wu X, Chung VC, Hui EP, Ziea ET, Ng BF, Ho RS, et al. Effectiveness of acupuncture and related therapies for palliative care of cancer: overview of systematic reviews. Sci Rep. 2015;5:16776. https://doi.org/10.1038/srep16776.
Brennan MT, Shariff G, Lockhart PB, et al. Treatment of xerostomia: a systematic review of therapeutic trials. Dent Clin N Am. 2002;46:847–56.
Alajbeg I, Falcão DP, Tran SD, MartÃn-Granizo R, Lafaurie GI, Matranga D, et al. Intraoral electrostimulator for xerostomia relief: a long-term, multicenter, open-label, uncontrolled, clinical trial. Oral Surg Oral Med Oral Pathol Oral Radiol. 2012;113:773–81.
Regelink G, Vissink A, Reintsema H. Efficacy of a synthetic polymer saliva substitute in reducing oral complaints of patients suffering from irradiation-induced xerostomia. Quintessence Int. 1998;29:383–8.
Epstein JB, Emerton S, Le ND, Stevenson-Moore P. A double-blind crossover trial of oral balance gel and Biotene toothpaste versus placebo in patients with xerostomia following radiation therapy. Oral Oncol. 1999;35:132–7.
Zero DT. Dentifrices, mouthwashes, and remineralization/caries arrestment strategies. BMC Oral Health. 2006;6(Suppl 1):S9.
Ship JA, McCutcheon JA, Spivakovsky S, et al. Safety and effectiveness of topical dry mouth products containing olive oil, betaine, and xylitol in reducing xerostomia for polypharmacy-induced dry mouth. J Oral Rehabil. 2007;34:724–32.
Turner MD. Hyposalivation and Xerostomia: etiology, complications, and medical management. Dent Clin North Am. 2016;60:435–43.
Hahnel S, Behr M, Handel G, Bürgers R. Saliva substitutes for the treatment of radiation-induced xerostomia – a review. Support Care Cancer. 2009;17:1331–43.
Fox PC, Brennan M, Pillemer S, et al. Sjögren’s syndrome: a model for dental care in the 21st century. J Am Dent Assoc. 1998;129:719–28.
Atkinson JC, Wu A. Salivary gland dysfunction: causes, symptoms, treatment. J Am Dent Assoc. 1994;125:409–16.
Fox PC. Management of dry mouth. Dental Clin N Am. 1997;41:863–76.
Gupta N, Pal M, Rawat S, Grewal MS, Garg H, Chauhan D, et al. Radiation-induced dental caries, prevention and treatment - a systematic review. Natl J Maxillofac Surg. 2015;6:160–6.
American Dental Association Council on Scientific Affairs. The use of dental radiographs: update and recommendations. J Am Dent Assoc. 2006;137:1304–12.
Jansma J, Vissink A, ‘s-Gravenmade EJ. In vivo study on the prevention of post-radiation caries. Caries Res. 1989;23:172–8.
Chalmers JM. Minimal intervention dentistry: part 1. Strategies for addressing the new caries challenge in older patients. J Can Dent Assoc. 2006;72:427–33.
Anusavice KJ. Dental caries: risk assessment and treatment solutions for an elderly population. Compend Contin Educ Dent. 2002;23(10 Suppl):12–20.
Walsh L. Lifestyle impacts on oral health. In: Mount G, Hume W, editors. Preservation and restoration of tooth structure. Middlesbrough: Knowledge Books and Software Ltd; 2005. p. 83–110.
Van Loveren C. Sugar alcohols: what is the evidence for caries-preventive and caries-therapeutic effects? Caries Res. 2004;38:286–93.
Guggenheimer J, Moore PA. Xerostomia: etiology, recognition and treatment. J Am Dent Assoc. 2003;134:61–9.
Tanida T, Okamoto T, Okamoto A, et al. Decreased excretion of antimicrobial proteins and peptides in saliva of patients with oral candidiasis. J Oral Pathol Med. 2003;32:586–94.
Daniels TE, Fox PC. Salivary and oral components of Sjogren’s syndrome. Rheum Dis Clin N Am. 1992;18:571–89.
Jha N, Seikaly H, Harris J, Williams D, Liu R, McGaw T, et al. Prevention of radiation induced xerostomia by surgical transfer of submandibular salivary gland into the submental space. Radiother Oncol. 2003;66:283–9.
Seikaly H, Jha N, Harris JR, Barnaby P, Liu R, Williams D, et al. Long-term outcomes of submandibular gland transfer for prevention of postradiation xerostomia. Arch Otolaryngol Head Neck Surg. 2004;130:956–61.
Jha N, Seikaly H, Harris J, Williams D, Sultanem K, Hier M, et al. Phase III randomized study: oral pilocarpine versus submandibular salivary gland transfer protocol for the management of radiation-induced xerostomia. Head Neck. 2009;31:234–43.
Sood AJ, Fox NF, O'Connell BP, Lovelace TL, Nguyen SA, Sharma AK, et al. Salivary gland transfer to prevent radiation-induced xerostomia: a systematic review and meta-analysis. Oral Oncol. 2014;50:77–83.
Hagen R, Scheich M, Kleinsasser N, Burghartz M. Two-stage autotransplantation of human submandibular gland: a novel approach to treat postradiogenic xerostomia. Eur Arch Otorhinolaryngol. 2016;273:2217–22.
Delporte C, O’Connell BC, He X, Lancaster HE, O'Connell AC, Agre P, et al. Increased fluid secretion after adenoviral-mediated transfer of the aquaporin-1 cDNA to irradiated rat salivary glands. Proc Natl Acad Sci U S A. 1997;94:3268–73.
Preston GM, Agre P. Isolation of the cDNA for erythrocyte integral membrane protein of 28 kilodaltons: member of an ancient channel family. Proc Natl Acad Sci U S A. 1991;88:11110–4.
Shan Z, Li J, Zheng C, Liu X, Fan Z, Zhang C, et al. Increased fluid secretion after adenoviral-mediated transfer of the human aquaporin-1 cDNA to irradiated miniature pig parotid glands. Mol Ther. 2005;11:444–51.
Baum BJ, Zheng C, Alevizos I, Cotrim AP, Liu S, McCullagh L, et al. Development of a gene transfer-based treatment for radiation-induced salivary hypofunction. Oral Oncol. 2010;46:4–8.
Baum BJ, Alevizos I, Zheng C, Cotrim AP, Liu S, McCullagh L, et al. Early responses to adenoviral-mediated transfer of the aquaporin-1 cDNA for radiation-induced salivary hypofunction. Proc Natl Acad Sci U S A. 2012;109:19403–7.
Aure MH, Konieczny SF, Ovitt CE. Salivary gland homeostasis is maintained through acinar cell self-duplication. Dev Cell. 2015;33:231–7.
Nanduri LS, Maimets M, Pringle SA, van der Zwaag M, van Os RP, Coppes RP. Regeneration of irradiated salivary glands with stem cell marker expressing cells. Radiother Oncol. 2011;99:367–72.
Nanduri LS, Baanstra M, Faber H, Rocchi C, Zwart E, de HG, et al. Purification and ex vivo expansion of fully functional salivary gland stem cells. Stem Cell Rep. 2014;3:957–64.
Lombaert IM, Brunsting JF, Wierenga PK, Faber H, Stokman MA, Kok T, et al. Rescue of salivary gland function after stem cell transplantation in irradiated glands. PLoS One. 2008;3:e2063.
Nanduri LS, Lombaert IM, van der Zwaag M, Faber H, Brunsting JF, van Os RP, et al. Salisphere derived c-kit+ cell transplantation restores tissue homeostasis in irradiated salivary gland. Radiother Oncol. 2013;108:458–63.
Feng J, van der Zwaag M, Stokman MA, van OR, Coppes RP. Isolation and characterization of human salivary gland cells for stem cell transplantation to reduce radiation-induced hyposalivation. Radiother Oncol. 2009;92:466–71.
Pringle S, van OR, Coppes RP. Concise review: adult salivary gland stem cells and a potential therapy for xerostomia. Stem Cells. 2013;31:613–9.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2018 Springer International Publishing AG, part of Springer Nature
About this chapter
Cite this chapter
Vissink, A., Spijkervet, F.K.L., Brennan, M.T. (2018). Xerostomia and Dental Problems in the Head and Neck Radiation Patient. In: Olver, I. (eds) The MASCC Textbook of Cancer Supportive Care and Survivorship. Springer, Cham. https://doi.org/10.1007/978-3-319-90990-5_24
Download citation
DOI: https://doi.org/10.1007/978-3-319-90990-5_24
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-319-90989-9
Online ISBN: 978-3-319-90990-5
eBook Packages: MedicineMedicine (R0)